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BACKGROUND AND AIMS 
• Kawasaki disease (KD) is an idiopathic acute systemic vasculitis.  
• Arthritis is a common manifestation (30%)1 not always evaluated.  
































• Descriptive study during a 15-year period. 
• Inclusion criteria: all children with the diagnosis of KD2. Arthritis was 
characterized. 
• Clinical, coronary involvement and laboratory data and treatment 
response were evaluated.  
• Non-parametric tests were used. Level of significance =0.05. 
1 GONG GW et al. Arthritis presenting during the acute phase of Kawasaki disease. J Pediatr 2006; 148: 800-5 
2 NEWBURGER JW et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease – AHA Scientific 
Statement. Circulation 2004; 110:2747-2771. 
































n = 63 
Gender 60.3% boys 
Age  Median 2 years 




Complete KD 68.3% 
Days to 
treatment 
Median 6.5  
(min 4; max 7) 
Arthritis in KD 12.7% (8/63) | 0,85/y 
PRESENTATION 
75% Early (≤10 days)  Late (>10 days)   25% 
62.5% Oligoarthritis  Poliarthritis   37.5% 
LARGE JOINTS were involved in ALL patients 
Days of disease  
to arthritis 
Median 4.5 
 (min 2; max 14) 
Aditional therapy KD Aspirin 
Additional therapy for 
arthritis 
Other NSAIDs 
Duration of arthritis 
Median 14 days  
(min 2; max 22) 
RESULTS  2 





























WITH  Arthritis 
N=8 
 NO Arthritis 
N=55 
p* 
Age – median (p25;p75) 3.0 (2.5; 4.8) 1.8 (0.9; 3.0) p=0,025 
Male sex  7.9% 52.4% p=0.893 
Days of fever to diagnosis  
– median (p25;p75) 
7.0 (5.0; 9.0) 6.5 (6.0; 14.0) p=0.520 
Complete KD 75% 67.3% P=0.717 
Cardiac involvement  37.5% 30.9% p= 0.701 
CrP - mean 127.72mg/L  109.36mg/L p=0.505 
Need for 2nd IVIG 37.5%  14.5%  p=0.137  
* Level of significance =0.05 
All recovered with no joint sequelae 
CONCLUSIONS 
• This study shows the importance of a systematic evaluation of articular 
involvement in KD.  
 
• It’s a short-lived phenomenon, predominantly with early presentation 
and involving larger joints3.  
 
• Patients are older and showed a tendency for less response to initial 
IVIG. Possibly the small size of sample didn't allow a statistical 
significance. 
 
• Its expression can be sufficiently relevant to lead clinicians to 






























3 IZUMI G, et al. Arthritis associated with Kawasaki disease: MRI findings and serum matrix metalloproteinase-3 profiles. Pediatr 
Int. 2011 Dec;53(6):1087-9. 
4 KOMATSU H, TATENO A. Failure to distinguish systemic-onset juvenile idiopathic arthritis from incomplete Kawasaki disease in 
an infant. J Paediatr Child Health. 2007 Oct;43(10):707-9. 
